The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men
NCT01800370 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2014-05-12
Summary
Aging in men reduces the amount of luteinizing hormone (LH) and testosterone (Te) secreted in each burst. Stress-associated mechanisms introduced by acute illness and chronic disease decrease LH and Te secretion further. A major unresolved issue is whether the aging process heightens the negative effects of a stressor (whether physical or metabolic) upon LH and Te secretion. This study will assess LH and Te secretion in response to a physical stressor (maximal exercise) and a common metabolic stressor (hyperglycemia) as a function of age in healthy men ages 18-80 yr.
Conditions
- Healthy
Interventions
- DRUG
-
Hyperglycemia
Hyperglycemia (rest controlled) will be induced by i.v. injection of 25 mL of dextrose 50% over 3 minutes with the subject supine.
- DRUG
-
Saline
Saline (rest controlled) will be induced by i.v. injection of 25 mL of saline over 3 minutes with the subject supine.
- OTHER
-
Exercise
Monitored exercise of 7-minute biking, 2-minute arm weights and a blood draw at the 10-minute time point will be repeated 3 times,which takes 30 minutes. Bilateral arm curls begin at 20 pounds and decrease by 5 pounds as needed to sustain 2 minutes of exercise at a rate of 1 complete curl every 2 seconds.
- PROCEDURE
-
Blood Draws
Blood will be sampled every 10 min from 0700 to 1300 h. Each intervention will begin at 0800 h after 1 h of baseline sampling, and be completed by 0900 h. Intervention is followed by 4 additional h of sampling to capture recovery (total sampling 6 h). Ten-min samples are for Te, LH, ACTH, cortisol, and GH. Glucose will be checked every 30 min. At 07000 h an archival serum sample will be obtained for safety-monitoring purposes.
- OTHER
-
Fasting procedure
Beginning at 1900 h on the evening prior to each study visit, subjects will remain fasting except for water, diet soda, and other non-caloric and non-caffeinated fluids, until 1300 h the next day.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Johannes Veldhuis, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- United States
Study Locations
More Related Trials
-
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
NCT05773183 ·Status: UNKNOWN
-
Insulin Sensitivity in Men With the Metabolic Syndrome
NCT00433173 ·Status: SUSPENDED ·Phase: NA
-
Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes
NCT00479609 ·Status: UNKNOWN ·Phase: PHASE3
-
Metabolomics During Testosterone Therapy
NCT01963390 ·Status: COMPLETED
-
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
NCT00372008 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations
NCT00857961 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone, Metformin, or Both, for Hypogonadism in Obese Males
NCT02514629 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men
NCT00696748 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene
NCT02651688 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Male Hormones on Regional Fat Metabolism
NCT01160328 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men
NCT00365794 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men
NCT01294319 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
NCT00309855 ·Status: COMPLETED ·Phase: PHASE1
-
Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men
NCT00957801 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men
NCT00470990 ·Status: COMPLETED ·Phase: NA
-
Autonomic Manifestations of Testosterone Deficiency in Men
NCT02715713 ·Status: WITHDRAWN
-
Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone?
NCT05964920 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Diurnal Testosterone Concentration
NCT03091296 ·Status: COMPLETED
-
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
NCT04456296 ·Status: COMPLETED ·Phase: PHASE4
-
Testosterone Replacement in Older Men and Atherosclerosis Progression
NCT00287586 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
NCT00114114 ·Status: COMPLETED ·Phase: NA
-
Exercise and Testosterone Therapy in Elderly Men With Physical Frailty
NCT00345969 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Resistance and Testosterone in Women
NCT00123110 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)
NCT00254553 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients
NCT00847314 ·Status: COMPLETED